Treat overall risk rather than LDL, two doctors urge

01/26/2012 | TheHeart.org (Montreal) (free registration)

The national panel writing education and treatment guidelines on cholesterol should abandon low-density lipoprotein targets in favor of an approach that takes overall cardiovascular risk into account, two physicians write in a letter published in the journal Circulation: Cardiovascular Quality and Outcomes. "What we know is that statins reduce risk, but they ought to be concentrated in people at higher risk," said Dr. Harlan Krumholz of the Yale University School of Medicine.

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA